An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 170
- 试验地点
- 9
- 主要终点
- Change in Insulin Use
研究概览
简要总结
The study intends to audit the impact of optimal insulin injection technique on clinical parameters and self-care behaviour of insulin treated diabetes patients in a prospective manner with a follow-up of 6 months. The optimal injection technique is delivered through education via a multimodal tailored approach augmented with a digital 'tailorable' patient learning platform .
The study is conducted in multiple sites across Belgium. Diabetes patients with or without lipohypertrophy will be entered into the audit. The end points will include the impact on use of insulin, long term blood glucose control (HbA1c), hypoglycaemia, glucose variability, needle reuse, patient injection habits and clinician education, training and information inputs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 1 Diabetes Mellitus, or Type 2 Diabetes Mellitus
- •Injecting insulin for at least 1 year
- •Self-managing injection therapy, including daily glucose monitoring
- •Access to a device with internet
- •Confident in navigating the internet
排除标准
- •Pregnant or likely to become pregnant during study period
- •Impaired cognitive ability which would prevent informed consent
- •Syringe only user
- •Insulin pump user
- •Glucagon-Like Peptide (GLP)-1 receptor agonists therapy only
研究组 & 干预措施
optimal injection technique
Subjects will be trained on site regarding optimal insulin injection technique, including avoiding injections in lipohypertrophy areas and proper rotation. Furthermore subjects are provided with access codes to watch online training modules on the Becton Dickinson (BD) and Me(TM) platform
干预措施: training in optimal insulin injection technique (Behavioral)
结局指标
主要结局
Change in Insulin Use
时间窗: up to 6 months
Change in Total Daily Dose of insulin for subjects at baseline and after 6 months; expressed as % and units/24 hrs
次要结局
- Change in Needle Re-Use(up to 6 months)
- Change in Glycemic Control(up to 6 months)
- Incidence of Hypoglycemic Events(up to 6 months)